Pharmafile Logo
Pharmafocus logo
Advanced Search

AstraZeneca, Novo and Enlight sign collaborative research deal

December 20, 2011
Research and Development, Sales and Marketing AstraZeneca, Enlight, Novo Nordisk

AstraZeneca and Novo Nordisk have linked up with a US biosciences firm in a bid to enhance their R&D operations. …

News

Pharma manufacturing news in brief

December 20, 2011
Manufacturing and Production ADC Biotechnology, BioMarin, GE Healthcare, Lonza and Neptune Technologies, M+W Group

Facility news from BioMarin, Lonza and Neptune Technologies, plus plans to boost biomanufacturing capacity in the developing world and new …

News

Akzo Nobel warned by FDA over Mexican facility

December 20, 2011
Manufacturing and Production Akza Nobel, manufacturing

Akzo Nobel has been taken to task by the US FDA for manufacturing standards at one of its active pharmaceutical …

News

AstraZeneca posts drug failures, takes $382m hit

December 20, 2011
Research and Development, Sales and Marketing AstraZeneca, depression, ovarian cancer

AstraZeneca has taken a major blow to its late stage pipeline, with one of its key cancer drugs now being …

News
Brilique picture

Brilique recommended for use by Germany’s pricing watchdog

December 19, 2011
Sales and Marketing AstraZeneca, Brilique, Plavix

Germany’s new pricing committee has said that AstraZeneca’s Brilique is a cost effective treatment for patients with a certain heart …

News

Ex-EMA chief ran consultancy firm whilst still in office

December 19, 2011
Sales and Marketing EMA, Lonngren, NDA

The former head of the European Medicines Agency Thomas Lonngren set up his own consultancy business to advise pharma whilst …

News
Gilenya picture

Key product launches of 2011

December 19, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2011, Actos, Benlysta, Brilique, Eliquis, Eylea, Incivek, Jevtana, Multaq, Victrelis, Xalkori, Yervoy, Zytiga, avastin, gilenya, key products

 Avastin 2011 saw a handful of high profile drugs suffer because of new safety and efficacy concerns. Chief among these …

Feature

Vertex chief to step down; names Jeffrey Leiden as new leader

December 19, 2011
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Abbott, Vertex

Vertex has named a new chief executive to succeed Matthew Emmens, who will retire early next year. He will be …

Appointment

Priorclave Success at London Vet show

December 19, 2011
Manufacturing and Production

During the recent London Vet Show the autoclave featured on the Southwest Medical stand R30 certainly proved a popular visitor …

News
Press release

University Teaching Labs Buy into Priorclaves for Better Performance

December 19, 2011
Manufacturing and Production

York University is shortly taking delivery of a number of priorclaves for use in the Biology Department’s Teaching Laboratories and …

News
Press release
Sanofi picture

Sanofi sheds dermatology unit for $423 million

December 19, 2011
Manufacturing and Production, Sales and Marketing Canada, Dermik, Sanofi

Sanofi has completed the sale of its Canadian-based dermatology business Dermik for $422.5 million.  The unit has been sold to …

News
Roche picture

EMA panel gives positive opinion for Roche’s Zelboraf

December 16, 2011
Sales and Marketing EMA, Roche, Zelboraf

The EMA’s advisory committee is recommending the approval of Roche’s skin cancer drug Zelboraf.  The European regulator’s Committee for Medicinal …

News
Lansley Hammond

Best Moments of 2011

December 16, 2011
Business Services, Medical Communications NHS, NHS reforms

 Health Secretary Andrew Lansley was on the end of a verbal battering by GP and journalist Dr Phil Hammond on …

News

Amgen’s chief executive and chairman Kevin Sharer to retire

December 16, 2011
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Amgen

Kevin Sharer, Amgen’s chairman and chief executive, has announced his retirement next year, leading the way for Robert Bradway to …

Appointment
Chandler Chicco's Bob Chandler

Chandler Chicco acquires German comms firms

December 16, 2011
Medical Communications Chandler Chicco, Haas & Health Partner Public Relations, SanCom Creative Communication Solutions.

Chandler Chicco Companies is to acquire German healthcare communication firms, Haas & Health Partner Public Relations and SanCom Creative Communication …

News
Victrelis picture

Merck and Roche begin combination hep C trial

December 16, 2011
Research and Development, Sales and Marketing Copegus, Merck, Pegasys, Roche, Victrelis

Merck and Roche have started clinical trials to investigate combinations of their hepatitis C drugs. The first trial is designed …

News

BMS in cholesterol alliance with China’s Simcere

December 16, 2011
Sales and Marketing BMS, CETP inhibitor, Simcere, cardiovascular, emerging markets

Bristol-Myers Squibb is to co-develop a new compound to treat cardiovascular disease with Chinese firm Simcere Pharmaceutical Group. The companies, …

News
lisaanson_web

Lisa Anson appointed as president of AstraZeneca’s UK marketing

December 15, 2011
Business Services, Manufacturing and Production, Medical Communications, Sales and Marketing AstraZeneca, Lisa Anson

AstraZeneca has appointed Lisa Anson as its new president for the firm’s UK marketing company, effective 1 January 2012.  Anson …

Appointment
Elephant sign picture

Optimising your brand – one bite at a time

December 15, 2011
Business Services, Medical Communications, Sales and Marketing Alex Blyth, MSI, brand, marketing

Brand managers invest a huge amount of time every year preparing brand plans – but often without really knowing what …

Feature
Novartis picture

Novartis opens cell-based flu vaccine plant in US

December 15, 2011
Manufacturing and Production Novartis, celll-based, vaccines

Novartis has officially started production at a first-of-its kind cell-based manufacturing facility for influenza vaccines in North Carolina, US. The …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026